Free Trial
NASDAQ:NUVL

Nuvalent (NUVL) Stock Price, News & Analysis

Nuvalent logo
$82.88 -0.98 (-1.16%)
As of 12:57 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Nuvalent Stock (NASDAQ:NUVL)

Advanced

Key Stats

Today's Range
$82.00
$83.95
50-Day Range
$72.16
$86.48
52-Week Range
$55.53
$106.32
Volume
77,627 shs
Average Volume
518,141 shs
Market Capitalization
$5.98 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$118.89
Consensus Rating
Moderate Buy

Company Overview

Nuvalent Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
65th Percentile Overall Score

NUVL MarketRank™: 

Nuvalent scored higher than 65% of companies evaluated by MarketBeat, and ranked 351st out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Nuvalent has received a consensus rating of Moderate Buy. The company's average rating score is 2.91, and is based on 9 buy ratings, no hold ratings, and 1 sell rating.

  • Upside Potential

    Nuvalent has a consensus price target of $118.89, representing about 43.3% upside from its current price of $82.95.

  • Amount of Analyst Coverage

    Nuvalent has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Nuvalent's stock forecast and price target.
  • Earnings Growth

    Earnings for Nuvalent are expected to decrease in the coming year, from ($3.86) to ($4.37) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Nuvalent is -16.92, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Nuvalent is -16.92, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Nuvalent has a P/B Ratio of 5.53. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Nuvalent's valuation and earnings.
  • Percentage of Shares Shorted

    11.93% of the float of Nuvalent has been sold short.
  • Short Interest Ratio / Days to Cover

    Nuvalent has a short interest ratio ("days to cover") of 10.9, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Nuvalent has recently decreased by 2.91%, indicating that investor sentiment is improving.
  • Dividend Yield

    Nuvalent does not currently pay a dividend.

  • Dividend Growth

    Nuvalent does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    11.93% of the float of Nuvalent has been sold short.
  • Short Interest Ratio / Days to Cover

    Nuvalent has a short interest ratio ("days to cover") of 10.9, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Nuvalent has recently decreased by 2.91%, indicating that investor sentiment is improving.
  • News Sentiment

    Nuvalent has a news sentiment score of 0.64. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for Nuvalent this week, compared to 6 articles on an average week.
  • Search Interest

    4 people have searched for NUVL on MarketBeat in the last 30 days. This is an increase of 33% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added Nuvalent to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Nuvalent insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $11,751,861.00 in company stock.

  • Percentage Held by Insiders

    10.20% of the stock of Nuvalent is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    97.26% of the stock of Nuvalent is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Nuvalent's insider trading history.
Receive NUVL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nuvalent and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NUVL Stock News Headlines

Nuvalent (NASDAQ:NUVL) CFO Sells $645,055.88 in Stock
Gold surges past $3,600 … but this has beat gold by 1,000x
Gold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real opportunity isn’t in coins or bullion. In every major gold rally of the past 50 years, there’s been another investment that has delivered dramatically higher returns.tc pixel
Nuvalent (NASDAQ:NUVL) Insider Sells $293,641.75 in Stock
Nuvalent, Inc. (NASDAQ:NUVL) Receives $119.50 Average PT from Analysts
See More Headlines

NUVL Stock Analysis - Frequently Asked Questions

Nuvalent's stock was trading at $78.28 at the start of the year. Since then, NUVL stock has increased by 6.0% and is now trading at $82.95.

Nuvalent, Inc. (NASDAQ:NUVL) released its quarterly earnings results on Thursday, August, 7th. The company reported ($1.31) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.27) by $0.04.

Nuvalent (NUVL) raised $151 million in an initial public offering on Thursday, July 29th 2021. The company issued 8,900,000 shares at a price of $16.00-$18.00 per share.

Shares of NUVL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nuvalent investors own include Humana (HUM), NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), American Water Works (AWK), Arista Networks (ANET) and e.l.f. Beauty (ELF).

Company Calendar

Last Earnings
8/07/2025
Today
10/07/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:NUVL
CIK
1861560
Fax
N/A
Employees
40
Year Founded
2017

Price Target and Rating

High Price Target
$140.00
Low Price Target
$100.00
Potential Upside/Downside
+43.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.91
Research Coverage
11 Analysts

Profitability

EPS (Trailing Twelve Months)
($4.90)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$260.76 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-32.58%
Return on Assets
-30.14%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
13.57
Quick Ratio
13.57

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$14.99 per share
Price / Book
5.53

Miscellaneous

Outstanding Shares
72,110,000
Free Float
64,750,000
Market Cap
$5.98 billion
Optionable
Optionable
Beta
1.30

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:NUVL) was last updated on 10/7/2025 by MarketBeat.com Staff
From Our Partners